CL2011000647A1 -
Compounds derived from nitrogen heterocycles, smac protein binding inhibitors to iap; pharmaceutical composition that includes them; and its use in the treatment of proliferative diseases. (divisional of application 2234-2007).
- Google Patents
Compounds derived from nitrogen heterocycles, smac protein binding inhibitors to iap; pharmaceutical composition that includes them; and its use in the treatment of proliferative diseases. (divisional of application 2234-2007).
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to CL2011000647ApriorityCriticalpatent/CL2011000647A1/en
Publication of CL2011000647A1publicationCriticalpatent/CL2011000647A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Compuestos tiazol-pirrolidin derivados, inhibidores del enlace de la proteína Smac al iap; y composición farmacéutica que los comprende (Divisional Solicitud 2234-2007).Thiazol-pyrrolidin derivatives compounds, Smac protein binding inhibitors to iap; and pharmaceutical composition that includes them (Divisional Application 2234-2007).
CL2011000647A2011-03-252011-03-25
Compounds derived from nitrogen heterocycles, smac protein binding inhibitors to iap; pharmaceutical composition that includes them; and its use in the treatment of proliferative diseases. (divisional of application 2234-2007).
CL2011000647A1
(en)
Compounds derived from nitrogen heterocycles, smac protein binding inhibitors to iap; pharmaceutical composition that includes them; and its use in the treatment of proliferative diseases. (divisional of application 2234-2007).
Compounds derived from nitrogen heterocycles, smac protein binding inhibitors to iap; pharmaceutical composition that includes them; and its use in the treatment of proliferative diseases. (divisional of application 2234-2007).
Compounds derived from nitrogen heterocycles, smac protein binding inhibitors to iap; pharmaceutical composition that includes them; and its use in the treatment of proliferative diseases. (divisional of application 2234-2007).
Fused heterocyclic compounds derived from pyrimidinones, potent inhibitors of cdc7; pharmaceutical composition; and its use in the prevention or treatment of cancer.
Compounds derived from tricycles, protein kinase inhibitors; pharmaceutical composition that includes them; Useful in the treatment of oncological and immunological diseases.
Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors.
COMPOUNDS OF AMINOPYRIDINE DERIVATIVES AS KINASE INHIBITORS OF THE TAM FAMILY, PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOUNDS AND THERAPEUTIC USE THEREOF
Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections
Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.